Outcomes of SGLT-2 Inhibitor induced Euglycaemic Diabetic Ketoacidosis in North Queensland Intensive Care Units: a Retrospective Cohort Study

Leanne Hall
Role

Supervisor

Description

This study will examine all ICU outcomes, including but not limited to; mortality, length of stay, use of ventilator, pertaining to SGLT-2 inhibitor induced euglycaemic ketoacidosis over a period of 8 years at the nominated study sites. A secondary aim will be to compare these findings to ICU outcomes of diabetic ketoacidosis patients, sex/age/co-morbidity matched. The data will be analysed to primarily determine differences between both groups, with the aim to develop an understanding of the unique natural history and risk factors of euglycaemic ketoacidosis.

Date

04 Dec 2024 - 19 Feb 2029

Project Type

N/A

Keywords

euglycaemic ketoacidosis;diabetic ketoacidosis;intensive care;SGLT-2 Inhibitor

Funding Body

N/A

Amount

0

Project Team

Leanne Hall;Clare Heal